MyFinsight
Home
About
Contact
avtx: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, AVTX has $125,100K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
125,100
126,583
Temporary equity, values issued
-
0
Total liabilities, mezzanine equity and stockholders equity
125,100
126,583
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Restricted cash, current
portion
$90K
Prepaid expenses and
other current assets
$2,139K
Short-term investments
$84,654K
Cash and cash
equivalents
$26,963K
Restricted cash, net of
current portion
$210K
Goodwill
$10,502K
Property and equipment,
net
$542K
Total current assets
$113,846K
Total assets
$125,100K
Total liabilities,
mezzanine equity and...
$125,100K
Total stockholders
equity
$91,547K
Total liabilities
$33,553K
Accumulated deficit
-$434,802K
Accumulated other
comprehensive income
$41K
Additional paid-in capital
$526,290K
Other long-term
liabilities
$117K
Derivative liability,
non-current
$23,160K
Deferred tax liability,
net
$304K
Royalty obligation
$2,000K
Total current
liabilities
$7,972K
Common stock0.001 par
value 200,000,000...
$18K
Accrued expenses and
other current...
$7,498K
Accounts payable
$474K
Subscribe for Financial Insights
Avalo Therapeutics, Inc. (AVTX)
Avalo Therapeutics, Inc. (AVTX)